TARTAGNI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 379
EU - Europa 233
AS - Asia 127
AF - Africa 18
OC - Oceania 1
Totale 758
Nazione #
US - Stati Uniti d'America 378
GB - Regno Unito 91
CN - Cina 59
DE - Germania 45
VN - Vietnam 37
IN - India 19
IT - Italia 18
SE - Svezia 17
IE - Irlanda 14
UA - Ucraina 14
FR - Francia 10
RU - Federazione Russa 10
CI - Costa d'Avorio 8
EE - Estonia 8
JO - Giordania 8
ZA - Sudafrica 8
ID - Indonesia 3
GR - Grecia 2
AU - Australia 1
BG - Bulgaria 1
CA - Canada 1
CH - Svizzera 1
FI - Finlandia 1
PT - Portogallo 1
SC - Seychelles 1
SG - Singapore 1
TG - Togo 1
Totale 758
Città #
Southend 83
Fairfield 41
Dong Ket 37
Ashburn 34
Wilmington 31
Houston 27
Seattle 25
Chandler 22
Woodbridge 20
Princeton 17
Cambridge 16
Dublin 14
Ann Arbor 13
Bremen 11
Nanjing 10
Jacksonville 9
Jinan 9
Westminster 9
Abidjan 8
Amman 8
New York 8
Padova 8
San Diego 6
Shenyang 6
Dearborn 5
Nanchang 5
Saint Petersburg 5
Berlin 4
Falls Church 3
Hebei 3
Jiaxing 3
Ningbo 3
Norwalk 3
Semarang 3
Tianjin 3
Turin 3
Zhengzhou 3
Beijing 2
Bologna 2
Frankfurt Am Main 2
Guangzhou 2
Los Angeles 2
Medford 2
Mülheim 2
Shanghai 2
Tappahannock 2
Baotou 1
Dalian 1
Haikou 1
Hefei 1
Helsinki 1
Lomé 1
Mahé 1
Melbourne 1
Milan 1
Mountain View 1
Olalla 1
Paris 1
Parma 1
Petrozavodsk 1
Pune 1
San Venanzo 1
Sofia 1
Taizhou 1
Victoria 1
Wenzhou 1
Totale 556
Nome #
Antidiabetic properties of berberine: from cellular pharmacology to clinical effects. 111
2B02: SERUM URIC ACID LEVEL, BUT NOT RENAL FUNCTION OR ARTERIAL STIFFNESS, IS ASSOCIATED TO WORSE BLOOD PRESSURE CONTROL IN GENERAL PRACTICE: DATA FROM THE BRISIGHELLA HEART STUDY 110
Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence. 94
Safety and tolerability of injectable lipid-lowering drugs: a review of available clinical data 91
Proposal of a non-invasive approach for biomechanical follow-up of heart failure patients. 78
Nutraceuticals for metabolic syndrome management: from laboratory to benchside. 72
Diet, dietary supplements and age-related macular degeneration (AMD) 69
null 68
null 44
Dietary determinants of oxidized-low-density lipoprotein antibodies in a sample of pharmacologically untreated non-smoker subjects: data from the Brisighella heart study. 26
Nutraceuticals with lipid-lowering activity: do they have any effect beyond cholesterol reduction? 16
Totale 779
Categoria #
all - tutte 1.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 0 0 14
2019/2020252 42 8 2 13 20 26 31 35 41 11 7 16
2020/202183 23 8 1 5 0 1 1 4 11 2 3 24
2021/2022155 32 2 6 6 15 7 1 15 2 2 39 28
2022/2023167 12 15 6 24 4 11 10 9 46 8 13 9
2023/202446 8 11 3 0 3 11 1 2 1 2 4 0
Totale 779